WHO 2024 Hepatitis B Guidelines and Treatment-Eligible Rate Among Treatment-Naive Patients
This cross-sectional study compares rates of hepatitis B treatment eligibility among treatment-naive patients according to the World Health Organization (WHO) 2024 guidelines with eligibility rates across other international guidelines.
Authors
- Rui Huang (ORCID: https://orcid.org/0000-0002-3189-7960)
- Chao Wu (ORCID: https://orcid.org/0000-0002-1657-010X)
- Chuanwu Zhu (ORCID: https://orcid.org/0000-0002-9113-2046)
- Jian Wang (ORCID: https://orcid.org/0000-0002-9482-5227)
- Shaoqiu Zhang (ORCID: https://orcid.org/0009-0001-6385-2644)
Institutions
- Soochow University (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing University (CN)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.35777
- Citations
- 3
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16